In developing countries, it is challenging to identify women at risk of preterm labor and provide early treatment. As a consequence, preterm birth affects at least 1 in 10 babies globally and is a leading cause of infant mortality. Thus it is important to find a means to monitor early changes in the cervix such as collagen and water levels prior to childbirth.

Detailed description of the solution

The SMART Diaphragm monitors cervical collagen levels and wirelessly transmits information on low collagen levels to physicians. This early identification of at-risk women in remote areas can enable more rapid routing of patients to secondary health facilities.

Designed by

• Designed by: Larry Rand, MD (Project Leader) and colleagues at the University of California-San Francisco, USA. Website for the device available here.
• Manufacturer location: The University of California-San Francisco, USA

When and where it was tested/implemented

This device is currently being tested in San Francisco, California, USA.

Funding Source

This device received funding from the following sources:

• Gates Foundation Grand Challenge Round 6 Award. Link available here.
• Vodafone/mHealth Alliance ($50,000). Link available here.

References